Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 4/20 | 0.74 |
| ▸ | ACHE | P22303 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | CA9 | Q16790 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29306026 | 0.93 | APP (0.64) | APPACHEMAPTCA12CA2 | |
| SCHEMBL12064267 | 0.90 | ACHE (0.62) | APPACHEMAPTCA12CA2 | |
| SCHEMBL9611200 | 0.86 | APP (1.00) | APPACHEMAPTALDH1A1TDP1 | |
| SCHEMBL864945 | 0.86 | APP (1.00) | APPACHEMAPTALDH1A1TDP1 | |
| SCHEMBL4457730 | 0.86 | GRM5 (0.64) | APPACHEMAPTCA12CA2 | |
| SCHEMBL9445826 | 0.86 | GRM5 (0.64) | APPACHEMAPTCA12CA2 | |
| SCHEMBL9715647 | 0.83 | GRM5 (0.61) | APPACHEMAPTCA12CA2 | |
| SCHEMBL8469646 | 0.83 | ACHE (1.00) | ACHEMAPTCA2CA9CA1 | |
| SCHEMBL11887 | 0.83 | — | — | |
| SCHEMBL25490701 | 0.82 | APP (0.50) | APPACHEMAPTCA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023150908-A1 | LIQUID CRYSTAL COMPOSITION AND PREPARATION METHOD THEREFOR, AND DISPLAY PANEL | 京东方科技集团股份有限公司 | 2023-08-17 | — | — | WO | disclosed |
| US-11715607-B2 | Graphene macro-assembly-fullerene composite for electrical energy storage | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2023-08-01 | — | — | US | disclosed |
| US-11715607-B2 | Graphene macro-assembly-fullerene composite for electrical energy storage | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2023-08-01 | — | — | US | disclosed |
| US-20220005651-A1 | GRAPHENE MACRO-ASSEMBLY-FULLERENE COMPOSITE FOR ELECTRICAL ENERGY STORAGE | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2022-01-06 | — | — | US | disclosed |
| US-20180118574-A1 | GRAPHENE MACRO-ASSEMBLY-FULLERENE COMPOSITE FOR ELECTRICAL ENERGY STORAGE | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2018-05-03 | — | — | US | disclosed |
| US-20180118574-A1 | GRAPHENE MACRO-ASSEMBLY-FULLERENE COMPOSITE FOR ELECTRICAL ENERGY STORAGE | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2018-05-03 | — | — | US | disclosed |
| US-9870871-B1 | Graphene macro-assembly-fullerene composite for electrical energy storage | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2018-01-16 | — | — | US | disclosed |
| US-9870871-B1 | Graphene macro-assembly-fullerene composite for electrical energy storage | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2018-01-16 | — | — | US | disclosed |
| US-8106142-B2 | Polyacetylinic oligomers | THE BOEING COMPANY (US) | 2012-01-31 | — | — | US | disclosed |
| WO-2010114243-A2 | NOVEL COMPOUNDS FOR ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTRONIC DEVICE USING THE SAME | DOW ADVANCED DISPLAY MATERIALS,LTD. (KR) | 2010-10-07 | — | — | WO | disclosed |
| US-20100204485-A1 | POLYACETYLINIC OLIGOMERS | THE BOEING COMPANY | 2010-08-12 | — | — | US | disclosed |
| US-7381533-B2 | Electrodes linked via oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2008-06-03 | — | — | US | disclosed |
| US-7176146-B2 | Method of making a molecule-surface interface | WILLIAM MARSH RICE UNIVERSITY (US) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204485-A1 | POLYACETYLINIC OLIGOMERS | AADAC, ACMSD, ECPAS | APP 3468/4885ACHE 4535/4885MAPT 1019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.